Find Experts

Experts in Immunology
Priti Bajpai M.J.M. (MARC) BONTEN Rolee Sharma Douglas Darling Donald Demuth Alba Ruiz de Andrés Javier Martínez-Picado Prof. Sarat Kumar Dalai Prof. Sarat Kumar Dalai Julià Blanco Cezmi A. Akdis Dr Joanna Kirman Arianna Calcinotto Dennis W. McGee Liz Hedstrom Daniela Brina Joan Press Neil E. Simister Mausumi Sikdar (Nee Bhakta )  Asmita Das View More
Thomas J. Sayers

Cancer and Inflammation Program
The Center for Cancer Research
United States of America

Scientist Immunology
Biography

Dr. Thomas Sayers is a senior scientist with Leidos Biomedical Research, Inc. and works in collaboration with the Laboratory of Experimental Immunology in the Cancer and Inflammation Program. Dr. Sayers obtained his Ph.D. in biochemistry from the University of London and performed postdoctoral studies on purification of autoantigens at the Medical Clinic of the University of Tubingen, Germany. He also worked as a laboratory leader in the Department of Immunotherapy at the Sandoz Research Institute, Vienna, Austria, before coming to the NCI. 

Research Intrest

Cancer Biology, Immunology, Molecular Biology and Biochemistry 

List of Publications
Shanker A, Brooks AD, Jacobsen KM, Wine JW, Wiltrout RH, et al. (2009) Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity. Cancer Res. 69: 6615-23.
Shanker A, Brooks AD, Tristan CA, Wine JW, Elliott PJ, et al. (2008) Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody. J Natl Cancer Inst. 100: 649-62.
Sayers TJ, Brooks A, Koh C, Ma W, Seki N, et al. (2003) The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP. Blood. 102: 303-10.
Seki N, Hauakawa Y, Brooks AD, Wine J, Wiltrout RH, et al. (2003) Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer. Cancer Res. 63: 207-13.
Seki N, Brooks AD, Back TC, Carter CRD, Parsoneault EM, et al. (2002) Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin. J Immunol. 168: 3484-92.
Experts in United States of America
Jairaj K. Acharya John Belote Wayde Brown Aimée M. Dudley Jon P Mochel Rabaa M. Al-Rousan Chancellor, Renate Karen Lee Abt Lin Li Hui-Hsien Chou Hamed I. Aly Cory K. Adams Mark Ehrensberger Jose Buitrago Gerhard J. Barone Jacquelyne Adams Jon Calabria Shelley Cannady Susan B. Adams Stoica George Daniel E. Acuna Tal Amasay Jason R. Wiles Matthew H Andersen Brian Rothman View More